TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. HR 1518, the New Era of Preventing End-Stage Kidney Disease Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER New | — |
| CHRISTOPHER PORTER | — |
Pharmacy PHA
HR 946, Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER New | — |
| CHRISTOPHER PORTER | — |
Medical/Disease Research/Clinical Labs MED
HR 1262, S 932 Give Kids a Chance Act to renew PRV program
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER New | — |
| CHRISTOPHER PORTER | — |
Medicare/Medicaid MMM
Regulations regarding transparency, reimbursement and care, particularly regarding rare disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER | — |
| CHRISTOPHER PORTER | — |
Copyright/Patent/Trademark CPT
S.1040, to prohibit product hopping and for other purposes
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER | — |
| CHRISTOPHER PORTER | — |
Taxation/Internal Revenue Code TAX
H.R. 1414, Cameron's Law to increase Orphan Drug Tax Credit to 50%
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSE GALLAGHER | — |
| CHRISTOPHER PORTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.